Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 5, 2025Pharmacogenetics and PharmacogenomicsOpen Access

Ten years at the forefront of personalized medicine: from achievements to future transformation

View Full Paper
Ask AI
Bookmark
Share

Authors

ДСД. А. СычевDBD. Yu. BelousovКМК. Б. Мирзаев

Discussion

Loading...

Member takes

Overview

Review highlights advancements in pharmacogenetics and the need for integration in clinical practice.

Key Points

  • Pharmacogenetics has evolved significantly, identifying key genetic markers and their clinical applications, particularly in Russia.
  • The journal has published over 240 papers, influencing the development of algorithms based on polymorphisms like CYP2D6, VKORC1, and DPYD.
  • Barriers to implementation include high sequencing costs and lack of regulatory standards, particularly affecting clinical practice in Russia.
  • Future prospects involve establishing a National DNA Biobank and enhancing pharmacogenetics education for healthcare professionals.

Cite This Study

Сычев et al. (2025) studied this question.

synapsesocial.com/papers/68c239e5b210217d6477e4fdhttps://doi.org/10.37489/2588-0527-2025-1-3-8
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Pharmacogenomics in Clinical Practice: Towards a Personalized Drug Therapy Paradigm2025
  2. 2Pharmacogenetic Testing — Evidence, Challenges, and Pathways to Adoption2025
  3. 3Pharmacogenetic testing in psychiatric practice2025
  4. 4Pharmacogenomics Applications in Clinical Practice: Revolutionizing Patient Care2025
  5. 5Pharmacogenomics for sustainable drug development: A narrative review of precision medicine, green chemistry, and multi-omics innovation2025